Preliminary experience with FK506 in thoracic transplantation.
نویسندگان
چکیده
5: (supplll: 127. 9. Rothbarth PhH. Diepellioot RJA. Metselaar HJ. Nooyen Y. Velzing J, Weimar W. Rapid demonstration of cytOmegalovirus in clinical specimens. Infection 1987; 15: 22810. Billingham ME. Diagnos\.l of rejection ot' endomyocardial biopsy. . J Heart Transplant 1982: 1: 25. 11. Son van WJ, The TH. Cytomegalovirus infection after organ traJllPlantation: an update WIth IpeCUIl emphasis on renal trans· piaDtation. Transplant lnt 1989; 2: 147.
منابع مشابه
Post-Intubation Tracheoesophageal Fistula; A Nine-Year Experience
Introduction: Tracheoesophageal fistula (TEF) is a rare condition, which could be life-threatening if diagnosed late or mismanaged. Post-intubation TEF is the most common form of acquired, non-malignant TEF and is usually associated with tracheal stenosis, which makes the treatment more challenging. Here, we present our experience of managing 21 patients with post-intubation TEF. Materials & ...
متن کاملThe effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.
Plasma FK506 was studied in 49 liver, 13 heart, 3 double-lung or heart-lung, and 21 kidney recipients. The levels were correlated with the drug doses used, kidney function, and liver function. In all varieties of recipients, there was an early rise in the FK506 plasma levels that occurred at the time of intravenous administration of the drug. At the same time or shortly after, there were increa...
متن کاملFK 506 in solid organ transplantation.
FK506 (Prograf) is a new immunosuppressive agent, recently approved for use in solid organ transplants. The first use of FK506 was for the indication of refractory liver allograft rejection. This revealed a marked ability to reverse ongoing rejection, even in cases where chronic changes were observed. Between 50 and 70% of patients converted to FK506 had shown improvement. In long-term follow-u...
متن کاملConversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients.
The effect of conversion from cyclosporine-steroid immunosuppression to the new agent FK506 was studied in 96 liver allograft recipients who were experiencing graft dysfunction or cyclosporine toxicity. Patients were stratified according to the cause of graft dysfunction that ultimately led to conversion to FK506. Response to FK506 introduction was monitored pathologically and biochemically. Th...
متن کاملCombined immunosuppressive therapy with low dose FK506 and antimetabolites in rat allogeneic heart transplantation.
Following rat heterotopic heart allotransplantation, low to lethal doses of the antimetabolites mizoribine (MIZ), RS-61443 (RS), and AZA were given alone or in combination with subtherapeutic doses of FK506 (0.04 mg/kg/day) for 14 days after transplantation. With the median effect analysis of Chou and Kahan for quantitative drug interactions, substantial therapeutic synergism was demonstrated b...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Transplantation
دوره 52 1 شماره
صفحات -
تاریخ انتشار 1991